A. Farooq, B. Zulfiqar, and K. Asghar, “Indoleamine 2,3- Dioxygenase: A Novel Immunotherapeutic Target for Osteosarcoma”, J Cancer Allied Spec, vol. 9, no. 1, Sep. 2022.